scroll down
Global API CDMO Company
Walking with partners,
Creating value
Creating value
Technology-driven gene therapy CDMO
from oligonucleotide to xRNA
View our Science & TechnologyGlobal API CDMO Company
Walking with Partners, Creating Value
Walking with Partners, Creating Value
30+years
Track record
40+
Global CDMO Project
6.4mole
Oligo CDMO Capacity ('22)
1.0kg / year
mRNA CDMO Capacity
IR Library
- [Analyst Report] OP in line on growing oligonucleotide salesAug 11, 2022
- [Presentation] ST PHARM IR Presentation (August 2022)Aug 5, 2022
- [R&D Materials] STP0404 POSTER Presentation in CROI 2020May 26, 2022
- [Presentation] ST PHARM mRNA platformMay 20, 2022
- [Presentation] ST PHARM IR Presentation (April 2022)May 9, 2022